Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening interval

U Yousaf-Khan, C van der Aalst, PA de Jong… - Thorax, 2017 - thorax.bmj.com
Background In the USA annual lung cancer screening is recommended. However, the
optimal screening strategy (eg, screening interval, screening rounds) is unknown. This study …

Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening interval.

U Yousaf-Khan, C Aalst, PA Jong, M Heuvelmans… - 2017 - cabidigitallibrary.org
Background: In the USA annual lung cancer screening is recommended. However, the
optimal screening strategy (eg, screening interval, screening rounds) is unknown. This study …

Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening interval

U Yousaf-Khan, C van der Aalst, PA de Jong… - 2017 - pubmed.ncbi.nlm.nih.gov
Background In the USA annual lung cancer screening is recommended. However, the
optimal screening strategy (eg, screening interval, screening rounds) is unknown. This study …

Final screening round of the NELSON lung cancer screening trial: The effect of a 2.5-year screening interval

U Yousaf-Khan, C van der Aalst, P de Jong… - … international journal of …, 2017 - repub.eur.nl
Background In the USA annual lung cancer screening is recommended. However, the
optimal screening strategy (eg, screening interval, screening rounds) is unknown. This study …

Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening interval.

U Yousaf-Khan, C van der Aalst, PA de Jong… - Thorax, 2016 - europepmc.org
Background In the USA annual lung cancer screening is recommended. However, the
optimal screening strategy (eg, screening interval, screening rounds) is unknown. This study …

Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening interval

U Yousaf-Khan, C van der Aalst, PA de Jong… - Thorax, 2017 - research.rug.nl
Background In the USA annual lung cancer screening is recommended. However, the
optimal screening strategy (eg, screening interval, screening rounds) is unknown. This study …

[引用][C] Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening interval

U Yousaf-Khan, C van der Aalst, PA de Jong… - Thorax, 2016 - cir.nii.ac.jp
Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year
screening interval | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細 …

Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening interval

U Yousaf-Khan, C van der Aalst, PA de Jong… - Thorax, 2017 - search.proquest.com
Background In the USA annual lung cancer screening is recommended. However, the
optimal screening strategy (eg, screening interval, screening rounds) is unknown. This study …

[引用][C] Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening interval

U Yousaf-Khan, C Aalst, PA de Jong, MA Heuvelmans… - 2016 - repository.ubn.ru.nl
In the USA annual lung cancer screening is recommended. However, the optimal screening
strategy (eg, screening interval, screening rounds) is unknown. This study provides results of …

Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening interval

U Yousaf-Khan, C van der Aalst, PA de Jong… - Thorax, 2016 - thorax.bmj.com
Background In the USA annual lung cancer screening is recommended. However, the
optimal screening strategy (eg, screening interval, screening rounds) is unknown. This study …